MicroRNA-Based Prophylaxis in a Mouse Model of Cirrhosis and Liver CancerElisa Callegari, Massimo Negrini|Molecular Therapy — Nucleic Acids|2018Cited by 23
miR-199a-3p increases the anti-tumor activity of palbociclib in liver cancer modelsElisa Callegari, Massimo Negrini|Molecular Therapy — Nucleic Acids|2022Cited by 14
Targeting metabolic vulnerabilities: REV-ERB agonist SR9009 potentiates sorafenib efficacy in liver cancerSilvia Sabbioni, Elisa Callegari|Cell Death Discovery|2026Cited by 2